Prenetics, a Covid-19 Testing Startup, to Go Public in SPAC Merger

📆 2021/09/16 18:00:00
📰 WSJ

⏱ Reading Time:
9 sec. here
2 min. at publisher
📊 Quality Score:
News: 7%
Publisher: 63%

日本ニュースニュース

日本最新ニュース,日本見出し

Covid-19 testing startup Prenetics Group is going public in a deal valuing it at $1.25 billion—the latest in a string of medical diagnostic companies to go public via a SPAC

Hong Kong-based Prenetics Group Ltd. is going public on the Nasdaq Stock Market via a special-purpose acquisition company, in a deal that values the medical diagnostic startup at $1.25 billion.

Prenetics, whose revenue has surged during the coronavirus pandemic, will merge with Artisan Acquisition Corp. , a blank-check company founded by Adrian Cheng,

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。続きを読む:

コメントを書く

日本 最新ニュース, 日本 見出し

日本最新ニュース, 日本見出し